UCB-derived oligodendrocyte-like cells (intrathecal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCB-derived oligodendrocyte-like cells (intrathecal), covering 2025-09-08 to 2025-09-08. Get the full timeline:
Most recent: Clinical Trial Update: UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells [Phase 1]